Historical record - last NADAC effective date: 3/22/2023
Product Information
LEVOCETIRIZINE 5 MG TABLET is a generic product labeled by Vensun Pharmaceuticals, Inc., priced at $0.0725 per EA under NDC 42543071290. Its NADAC has been published 430 times since Jan 7, 2015.
FDA first approved this application on Sep 9, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Vensun Pharmaceuticals, Inc.NDC
42543071290
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/22/2023
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203646FDA Approved
9/9/2014
TE Code
AB
On Market Since
10/27/2014
Pharmacological Classes
Price Statistics
The NADAC for LEVOCETIRIZINE 5 MG TABLET has been published 430 times since Jan 7, 2015, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0725 per EA |
|---|---|
| All-time high | $0.2570 (Mar 11, 2015) |
| All-time low | $0.0646 (Jan 18, 2023) |
| Median price | $0.0997 |
| Average price | $0.1221 |
| Largest weekly change | +51.3% (Apr 18, 2018) |
| Weeks tracked | 430 |
| Tracking since | Jan 7, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+2.8%
All
-70.4%
Last surveyed Mar 29, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVOCETIRIZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 5 MG TABLET, manufactured by Vensun Pharmaceuticals, Inc., is $0.0725 per EA (NDC 42543071290), effective Mar 29, 2023.
How has the price of LEVOCETIRIZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOCETIRIZINE 5 MG TABLET has declined 70.4%. It has been tracked across 430 weekly CMS publications since Jan 7, 2015.
What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 5 MG TABLET?
Since Jan 7, 2015, the NADAC for LEVOCETIRIZINE 5 MG TABLET has ranged from a low of $0.0646 (Jan 18, 2023) to a high of $0.2570 (Mar 11, 2015), with a median of $0.0997 per EA.
Are there cheaper alternatives to LEVOCETIRIZINE 5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOCETIRIZINE 5 MG TABLET, is $0.0517 per EA — about 29% below LEVOCETIRIZINE 5 MG TABLET.
Who manufactures LEVOCETIRIZINE 5 MG TABLET?
LEVOCETIRIZINE 5 MG TABLET (NDC 42543071290) is labeled by Vensun Pharmaceuticals, Inc., and CMS classifies it as a generic product.